"We at Gender Plus are dismayed by NHS England's decision to stop new prescriptions of gender-affirming hormones (GAH) to under-18s. At Gender Plus Hormone Clinic (GPHC) - the only CQC Outstanding registered provider of care to transgender people from the age of 16 - we prescribe these medications where indicated following a rigorous process, in line with international best practice and guidance."
"16 and 17-year-olds are no longer able to access medication that several medical institutions have dubbed 'life-saving' after the public health service claimed evidence of its benefits remain 'really weak.' According to a BBC report, NHS England blocked new referrals after commissioning ten independent reviews into the benefits and drawbacks of under-18s using gender-affirming hormones such as testosterone or oestrogen."
NHS England has halted new prescriptions of gender-affirming hormones for 16 and 17-year-old transgender individuals, following recommendations from Dr Hilary Cass's review of trans youth healthcare. The decision was made after commissioning ten independent reviews examining the benefits and risks of hormone use in under-18s. Clinicians must now review existing prescriptions for young people already taking these medications. Gender Plus, the UK's only CQC-regulated transgender healthcare provider, expressed dismay at the decision, arguing it contradicts guidance from major medical institutions including the Endocrine Society, which supports hormone introduction in adolescence under appropriate conditions.
#transgender-healthcare #gender-affirming-hormones #nhs-policy #youth-healthcare #medical-regulation
Read at PinkNews | Latest lesbian, gay, bi and trans news | LGBTQ+ news
Unable to calculate read time
Collection
[
|
...
]